Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Ovarian Neoplasms 2Breast Neoplasms 2Urinary Bladder Neoplasms 1Sleep Wake Disorders 1Rectal Neoplasms 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Overweight 1Obesity 1Neoplasms 1Motor Activity 1Lung Neoplasms 1Locally Advanced Head and Neck Squamous Cell Carcinoma 1Kidney Neoplasms 1Hematologic Neoplasms 1Endometrial Neoplasms 1Depressive Disorder 1Colorectal Neoplasms 1Colonic Neoplasms 1Castration-Resistant Prostate Cancer (CRPC) 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Specimen Handling 1Psilocybin 1Interviews as Topic 1Counseling 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Depressive Disorder × Counseling × 30 days × Clear all
NCT07216404 2026-05-14

Psilocybin-Assisted Therapy for the Treatment of Major Depressive Disorder in Patients With Non-Small Cell Lung Cancer

Ohio State University Comprehensive Cancer Center

Phase 2 Recruiting
10 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Depressive Disorder

Data powered by HemOnc (CC BY 4.0) Colophon âš¡